 The study evaluated the durability of Tovaberol's clinical benefit in treating toenail onicomycosis and found that it provides durable clinical benefit, making it an attractive long-term treatment option for domatophyt associated onicomycosis of the toenail. This article was authored by Aditya K. Gupta, Steve Hall, Lee T. Zane, and others.